Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 85-95
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.85
Table 1 Biodemographic characteristics and hospitalization trends for 30 d readmissions of Crohn’s disease
VariableYear
2010
2012
2014
2016
2018
Number of readmissions62026580647582787672
Age (mean ± SE, yr) 41.8 ± 0.941.6 ± 1.141.2 ± 0.842.5 ± 0.743.9 ± 0.7
Gender (%)
Males45.544.045.746.746.5
Females54.556.054.353.353.5
Charlson comorbidity index score (%)
069.772.069.964.961.3
119.215.517.319.520.0
25.96.16.77.59.0
≥ 35.26.46.18.19.7
Insurance type (%)
Medicare20.529.129.328.930.6
Medicaid21.524.926.425.524.7
Private41.237.137.040.839.0
Uninsured8.88.97.34.85.7
Household income quartile (%)
1st 27.829.227.929.028.6
2nd 23.425.628.526.830.0
3rd 24.925.122.524.523.7
4th 23.920.121.119.717.7
Hospital characteristics
Hospital bed size (%)
Small9.99.914.213.315.0
Medium22.422.427.326.926.3
Large67.767.758.559.858.7
Teaching status (%)
Metropolitan non-teaching39.234.425.221.817.3
Metropolitan teaching52.156.868.472.377.0
Non-metropolitan8.78.86.45.95.7
Hospital volume quintiles (%)
Q11.81.91.51.71.3
Q24.35.45.14.24.5
Q310.310.010.28.410.4
Q419.418.118.118.619.1
Q564.264.665.167.164.7
Table 2 Biodemographic characteristics and hospitalization trends for 30 d readmissions of ulcerative colitis
VariableYear
20102012201420162018
Number of readmissions32723399342644494234
Age (mean ± SE, yr) 49.8 ± 1.649.6 ± 1.548.4 ± 1.149.9 ± 1.051.2 ± 0.8
Gender (%)
Males48.145.647.546.749.4
Females51.954.452.553.350.6
Charlson comorbidity index score (%)
057.859.660.655.650.9
120.320.018.619.420.7
29.49.08.510.610.3
≥ 312.511.412.314.418.1
Insurance type (%)
Medicare36.336.632.435.134.8
Medicaid17.817.022.317.519.5
Private39.437.040.142.240.4
Uninsured6.59.45.25.25.3
Household income quartile (%)
1st 25.529.226.527.225.0
2nd22.523.125.927.526.7
3rd 26.424.622.925.026.1
4th 25.623.124.720.322.2
Hospital characteristics
Hospital bed size (%)
Small10.29.813.213.516.8
Medium19.822.426.825.724.3
Large70.067.860.060.858.9
Teaching status (%)
Metropolitan non-teaching37.338.226.124.519.3
Metropolitan teaching53.653.567.770.376.3
Non-metropolitan9.18.36.25.24.4
Hospital volume quintiles (%)
Q12.42.42.52.12.0
Q26.07.45.95.85.5
Q311.810.511.710.312.3
Q420.220.119.020.421.4
Q559.659.660.961.458.8
Table 3 Readmission rates, inpatient mortality, and healthcare burden for 30 d readmissions of Crohn’s disease and ulcerative colitis
OutcomesYear
P trend
2010
2012
2014
2016
2018
Crohn’s disease
All-cause readmission rate (%)14.915.515.218.917.6< 0.001
Crohn’s disease specific readmission rate (%)7.16.97.08.98.2< 0.001
Crohn’s disease readmission proportion (%)54.951.853.055.854.60.002
Inpatient mortality (%)0.91.40.70.71.00.059
Mean length of stay (d)5.95.95.36.06.20.927
Mean total hospital cost (USD)12327130681098813421142600.210
Ulcerative colitis
All-cause readmission rate (%)14.114.213.516.615.70.003
Ulcerative colitis specific readmission rate (%)5.25.35.26.15.60.029
Ulcerative colitis readmission proportion (%)42.642.443.443.041.00.566
Inpatient mortality (%)2.51.82.22.02.30.912
Mean length of stay (d)6.86.86.36.86.90.452
Mean total hospital cost (USD)13783135681379015358159290.009